Walking and Dietary Modification for Recurrent Early Miscarriages
NCT03023137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 480
Last updated 2017-04-10
Summary
This study is part of a big one aiming to evaluate how lifestyle interventions during pregnancy affect obstetric results, neonatal metabolism and the intelligence of the offspring (study not yet completed). Data regarding obstetric and neonatal results were entered in NCT01409382, but we decided to split results in two for the sake of clarity.
A cohort of women with early pregnancy losses without antiphospholipid antibodies was selected for two reasons. One is that these women follow strictly the recommendadtions. The second is that no medication has been shown to increase the rate of take-home babies in women with early miscarriages who test negative for antiphospholipid antibodies. We decided to focus on the fibrinolytic system because trophoblast migration and placental vasculogenesis and angiogenesis depend on plasmin-dependent extracellular matrix remodeling. Plasminogen activator inhibitor (PAI)-1 inhibits the generation of plasmin. Since both glucose and insulin increase PAI-1 synthesis, hyperglycemia itself, or by stimulating insulin production, reduces plasmin generation, which may impair placentation.
Abnormalities in glucose metabolism may be also deleterious to embryos by causing epigenetic changes. Chromosomal abnormalities are considered an important cause of early pregnancy losses.
Several lines of evidence lend support to the hypothesis that carbohydrate metabolism abnormalities contribute to the pathogenesis of recurrent early pregnancy losses. One is that of the pregnancies of the women with polycystic ovary syndrome, around 30 and 50% end with first-trimester miscarriages. Hyperinsulinemia is a prevalent feature of the syndrome, and interventions proven effective in reducing insulin levels, such as metformin, have been shown to reduce the rate of early miscarriages. The other is that patients with body mass index of ≥25 kg/m2 have significantly higher odds of early miscarriage, regardless of the method of conception.
The investigator's hypothesis was that a balanced diet combined to regular exercise, by improving glucose homeostasis, would increase the take-home baby rate in women with consecutive early miscarriages. Moderate exercises are usually well tolerated not only by the mother, but also by the fetus, as indicated by tests of fetal well-being, including umbilical artery systolic to diastolic ratio.
Conditions
- Recurrent Miscarriage
Interventions
- BEHAVIORAL
-
Walking & dietary modification
1. Daily walking at a moderate pace (4 km/h) \> 40 min, 7/7. Those remaining seated most of the day should walk 25-30 min twice a day, avoiding \>12 h of physical inactivity. Walking may be replaced by stationary bicycle rides or swimming when convenient, which often occurred near term and when the mother was obese. 2. At least two daily servings of protein-rich food (≥ 4 g/kg of meat, poultry, fish or eggs) per day. Avoidance of high-carbohydrate, low-fiber meals, such as snacks, candies, fiber-free juices, coconut water or sugar-sweetened beverages. Sucralose could be used as a sweetener. Participants are recommended to use ondansetron for nausea and vomiting prevention
Sponsors & Collaborators
-
Hospital dos Servidores do Estado do Rio de Janeiro
lead OTHER_GOV
Principal Investigators
-
Silvia Hoirisch-Clapauch, MD, PhD · Hospital Federal dos Servidores do Estado
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2016-08-31
- Completion
- 2017-02-28
Countries
- Brazil
Study Locations
More Related Trials
-
The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
NCT02990403 ·Status: UNKNOWN ·Phase: PHASE4
-
Nutritional Deficiency and Recurrent Miscarriage
NCT05267678 ·Status: UNKNOWN
-
Aspirin, Heparin and Miscarriage
NCT01917799 ·Status: UNKNOWN ·Phase: PHASE4
-
First Trimester of Pregnancy: Impact of a History of Miscarriage on Women's Stress
NCT04841486 ·Status: COMPLETED
-
Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial
NCT02145767 ·Status: COMPLETED ·Phase: PHASE2
-
A Follow-up of the Early Pregnancy Study Cohort.
NCT01132924 ·Status: COMPLETED
-
Use of Platelet Indices for Prediction of Recurrent Miscarriage
NCT03710226 ·Status: COMPLETED
-
The Role of Prothrombin Gene and Methylenetetrahydrofolate Reductase(MTHFR) Gene Polymorphisms as Risk Factors for Recurrent Miscarriage
NCT03209063 ·Status: UNKNOWN
-
Exercise and Pregnancy: Randomized Clinical Trial
NCT00641550 ·Status: UNKNOWN ·Phase: NA
-
A Lifestyle Intervention to Improve in Vitro Fertilization Results
NCT02648555 ·Status: UNKNOWN ·Phase: NA
-
Mothers Working to Prevent Early Stillbirth Study 20-28
NCT06005272 ·Status: RECRUITING
-
Goals for Reaching Optimum Wellness (GROWell)
NCT02904473 ·Status: COMPLETED ·Phase: NA
-
A Study Looking at Women's Experiences After a Miscarriage
NCT01223482 ·Status: UNKNOWN
-
Markers of Oxidative Stress in a Early Week Miscarriage: Ischemia of Modified Albumin
NCT01988740 ·Status: UNKNOWN
-
Diet in Twin Pregnancy: the Wellness of Mother and Babies.
NCT05773677 ·Status: UNKNOWN ·Phase: NA
-
Hydroxychloroquine for Prevention of Recurrent Miscarriage.
NCT03165136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluation of a Decision Aid for Early Pregnancy Loss
NCT04410029 ·Status: COMPLETED ·Phase: NA
-
Comprehensive Assessment of Risks for Miscarriage.
NCT04456660 ·Status: RECRUITING
-
MAMA Tot - Healthy Weight Parallel Study
NCT06598098 ·Status: RECRUITING ·Phase: NA
-
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
NCT00550979 ·Status: UNKNOWN
-
Non-invasive Monitoring of Miscarriage
NCT06581692 ·Status: RECRUITING
-
Pregnancy Loss Between 15 and 22 Weeks SA Within the Network of Perinatal Pérriodof Western Brittany : Case Control Study PILOT STUDY CA
NCT03668743 ·Status: COMPLETED
-
Health Improvement After Pregnancy (HIP) Program Randomized Control Trial
NCT02077179 ·Status: TERMINATED ·Phase: NA
-
Meditation and Mindfulness for Recurrent Pregnancy Loss
NCT03905395 ·Status: UNKNOWN ·Phase: NA
-
The Use of Early Pregnancy HbA1c in Predicting Excessive Fetal Growth in Women at Risk of Glucose Intolerance
NCT04858386 ·Status: TERMINATED